Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?

MLA

Fanale, Daniele, et al. “Prognostic Role of Plasma PD-1, PD-L1, Pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?” Cancers, vol. 13, no. 9, May 2021, p. 2118. EBSCOhost, https://doi.org/10.3390/cancers13092118.

APA

Fanale, D., Incorvaia, L., Badalamenti, G., De Luca, I., Algeri, L., Bonasera, A., Corsini, L. R., Brando, C., Russo, A., Iovanna, J. L., Bazan, V., Roberta, M., & Hohenberger, P. (2021). Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival? Cancers, 13(9), 2118. https://doi.org/10.3390/cancers13092118

Chicago

Fanale, Daniele, Lorena Incorvaia, Giuseppe Badalamenti, Ida De Luca, Laura Algeri, Annalisa Bonasera, Lidia Rita Corsini, et al. 2021. “Prognostic Role of Plasma PD-1, PD-L1, Pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?” Cancers 13 (9): 2118. doi:10.3390/cancers13092118.